Literature DB >> 8411197

Characterization of a Mg-dependent, Na-inositol co-transport process in cardiac sarcolemmal vesicles.

L J Rubin1, C C Hale.   

Abstract

[3H]-myo-Inositol transport into cardiac sarcolemmal vesicles is both a time- and Na(+)-dependent process. Transport was stimulated 3-fold by 1 microM valinomycin suggesting the process is electrogenic. myo-Inositol transport was dependent upon the presence of Mn2+ or Mg2+ but not Ca2+. Kinetic analysis revealed a high affinity transport process that was saturable (Vmax, 650 +/- 71 pmoles myo-inositol/mg protein/min; Km, 37.7 +/- 1.3 microM) and a low affinity process that was unsaturable up to 1.0 mM substrate. Transport was not inhibited by 1.0 mM of either L-glucose, D- or L-galactose. However, D-glucose and L-fucose at 1.0 mM were inhibitory. Higher concentrations (30 mM) of each of the sugars inhibited transport. myo-Inositol transport was also inhibited by the inositol isomers (1.0 mM), D-chiro-inositol, epi-inositol and scyllo-inositol with scyllo-inositol being most effective. Kinetic analysis established scyllo-inositol as a competitive inhibitor of cardiac myo-inositol transport, increasing the Km for substrate three-fold (122 +/- 21 microM). These data indicate that inositol transport across cardiac sarcolemma is a Mg(2+)-dependent Na+ co-transport process that is electrogenic and stereospecific.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8411197     DOI: 10.1006/jmcc.1993.1084

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  4 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

2.  Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures.

Authors:  R E Isaacks; A S Bender; C Y Kim; M D Norenberg
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

3.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

4.  Sodium/myo-Inositol transporters: substrate transport requirements and regional brain expression in the TgCRND8 mouse model of amyloid pathology.

Authors:  Daniela Fenili; Ying-Qi Weng; Isabelle Aubert; Mark Nitz; JoAnne McLaurin
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.